Cassady Schiller Wealth Management’s Revolution Medicines RVMD Stock Holding History

Cassady Schiller Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.23K	Buy	+28	New	+$1.41K	﹤0.01%	734

Other funds holding RVMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cassady Schiller Wealth Management's RVMD Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Revolution Medicines (RVMD) in Q4 2024: 28 shares worth $1.23K. The stake represents ﹤0.01% of the portfolio and ranks #734 among its holdings.

281 funds tracked by Wall St. Rank hold RVMD as of Q4 2024.

Cassady Schiller Wealth Management held 28 shares of Revolution Medicines worth $1.23K as of Q4 2024.
Revolution Medicines was a new Cassady Schiller Wealth Management position in Q4 2024.
Revolution Medicines made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #734 holding.
281 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.